50,000th Patient Successfully Treated for Common Skin Cancer with GentleCure 

Dr. Jeffrey Keating is the 50,000th patient to have his nonmelanoma skin cancer successfully treated with GentleCure™.
GentleCure is the only treatment for basal and squamous carcinomas that uses ultrasound imaging to help clinicians direct low-level X-ray energy to targeted areas of the skin, killing cancer cells without surgery. Peer-reviewed studies show that the technology produces a 99.3 percent cure rate for early stage nonmelanoma skin cancers, making it just as effective as traditional Mohs surgery.
SkinCure Oncology is the only company that offers GentleCure-the most comprehensive approach to delivering advanced, nonsurgical treatment for common skin cancers using Image-Guided Superficial Radiation Therapy.
SkinCureOncology.com/about-us/The-GentleCure-Experience